Custom Animal-Derived Biological Products

About New Life Biologics

New Life Biologics is a private, commercial-stage biotechnology company specializing in the development and manufacturing of animal-derived biological products, primarily for the cell culture and diagnostics markets. Its core innovation is a proprietary plasma fractionation platform that creates sustainable, powder-form alternatives to traditional FBS and enhanced BSA products, addressing key industry pain points like batch variability, contamination risk, and supply chain instability. The company appears to be revenue-generating, selling directly to end-users in research and diagnostics, and is actively promoting its technology at industry conferences. Its strategic focus is on displacing incumbent serum products with more reliable and sustainable solutions.